: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Cervical Cancer, March 2026
Free Subscription

Abstracts
Retrieve all available abstracts of the following 435 articles:
HTML format

Single Articles

FU F, Wang T, Wu Z, Feng Y, et al
Retraction Note: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
Cell Death Dis. 2026;17:232.
PubMed

TONOMURA N, Yoshida K, Morita H, Nakai M, et al
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
Anticancer Res. 2026;46:1497-1506.
PubMed
Abstract available

GE Z, Zhang C, Zhang Z, Li J, et al
The causal effect of cytokine cycling levels on the risk of cervical cancer: A bidirectional 2-sample Mendelian randomization study.
Medicine (Baltimore). 2026;105:e47782.
PubMed
Abstract available

LI W, Liang X, Wu X, Zheng B, et al
RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway.
Arch Biochem Biophys. 2026 Feb 25:110777. doi: 10.1016/j.abb.2026.110777.
PubMed
Abstract available

BERTOLAZZI M, Genta ML, Lopes A, Fernandes R, et al
Randomized trial of autologous ovarian graft to preserve ovarian function in young women undergoing pelvic radiotherapy for cervical cancer.
Eur J Surg Oncol. 2026;52:111496.
PubMed
Abstract available

PECK LC, Petty MC, Walker AR, Huepenbecker SP, et al
Adherence to 2019 ASCCP Cervical Cancer Screening Guidelines at a Community Health Network.
J Low Genit Tract Dis. 2026 Feb 27. doi: 10.1097/LGT.0000000000000938.
PubMed
Abstract available

MENG N, Pan J, Wei W, Sun J, et al
Lymph Node Metastases Prediction in Cervical Cancer Using Time-Dependent Diffusion MRI and Macromolecular Proton Fraction Imaging.
Radiol Imaging Cancer. 2026;8:e250452.
PubMed
Abstract available

KUSAKABE H, Fukutome T, Suzuki H, Teramoto Y, et al
Single-organ vasculitis of the uterine cervix mimicking cervical cancer: A case report.
Case Rep Womens Health. 2026;49:e00787.
PubMed
Abstract available

XIONG J, Qian Y, Wang M, Sun X, et al
Factors associated with cervical cancer screening participation in Southwest China: a retrospective database-based cross-sectional study.
Front Med (Lausanne). 2026;13:1740068.
PubMed
Abstract available

SCHULTE-FROHLINDE R, Georges D, Clifford G, Baussano I, et al
Correction to "Predicting cohort-specific cervical cancer incidence from population-based surveys of human papilloma virus prevalence: a worldwide study".
Am J Epidemiol. 2026 Feb 27:kwae310. doi: 10.1093.
PubMed

KUMAR V, Bharti N, Ranjan R, Pal RR, et al
CRISPR-Cas9 Gene Editing: Promising Therapeutics for HPV-driven Cervical Cancer.
Curr Drug Targets. 2026 Feb 23. doi: 10.2174/0113894501437052251204164311.
PubMed

ILIA G, Thomopoulos A, Chronas D
Preserved Menstruation After Chemoradiotherapy in Stage IIIC1 Cervical Cancer: A Unique Case.
J Clin Med. 2026;15:1550.
PubMed
Abstract available

PRASERTPAKDI S, Suprasert P, Salakphet T, Khunamornpong S, et al
Cervical Cancer Screening: Histologic Outcomes of HPV-Negative HSIL/ASC-H Cytology in a Tertiary Referral Cohort in Northern Thailand.
Medicina (Kaunas). 2026;62:371.
PubMed
Abstract available

JULIANTI RA, Putra AD, Fuady A, Nuranna L, et al
Expression of miR-92a and miR-125b and Their Association with Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
Int J Mol Sci. 2026;27:1723.
PubMed
Abstract available

REZENDE B, Wolf B, Colman V, Oliveira R, et al
FIGO 2018 Versus Ontogenetic Staging for Locally Advanced Cervical Cancer: An International Multicenter Cohort Study Comparing the Two Classifications and Their Prognostic Implications.
Cancers (Basel). 2026;18:689.
PubMed
Abstract available

MULUGETA-GORDON L, Jang M, Dagher C, Nasioudis D, et al
Advances in the Surgical Management of Cervical Cancer.
Cancers (Basel). 2026;18:628.
PubMed
Abstract available

YOUSSEF J, El Masri A, Atwi M, Ibrahim E, et al
Molecular Targets of Cervical Cancer and Its Microenvironment: Advances in Treatment.
Cancers (Basel). 2026;18:563.
PubMed
Abstract available

KARAMI P, Yahya SI, Roshani S, Parandin F, et al
Enhanced design of a photonic crystal biosensor for early cervical cancer detection using refractive index variation and neural network classification.
Sci Rep. 2026 Feb 26. doi: 10.1038/s41598-026-41676.
PubMed

ZHAO X, Yang L, Pan J, Zeng Z, et al
Correction: CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.
Sci Rep. 2026;16:7718.
PubMed

MITTAL P, Kamalnath J, Charnalia M, Anjana AK, et al
Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes.
Brachytherapy. 2026 Feb 25:S1538-4721(25)00394.
PubMed
Abstract available

BOUGHRIOU M, Zendehdel K, Lotfi F, Gorgati E, et al
Cervical cancer in foreign-born women living in Italy: A systematic review of population-based studies.
Cancer Epidemiol. 2026;102:103029.
PubMed
Abstract available

MALIKOVA H, Graffneter K, Kremenova K, Burgetova R, et al
Pretreatment computed tomography L1 attenuation values: Easy reaching predicting factor for radiation-related bone insufficiency fractures in females treated for advanced cervical cancer (prospective study).
Womens Health (Lond). 2026;22:17455057261426799.
PubMed
Abstract available

ZHANG Y, Zhang J, Zhong M, Yu L, et al
A Novel Three-Dimension Printed Individualized Curved-Needle-Based Interstitial Brachytherapy for Re-Irradiation in Uterine Fundus-Involving Recurrent Cervical Cancer: A Case Report.
Curr Oncol. 2026;33:108.
PubMed
Abstract available

MERCIER NB, Khudina Y, Roberts L, Feely A, et al
Surgically Treated Cervical Cancer in Manitoba: A Retrospective Study of the Impact of Geography on Care.
Curr Oncol. 2026;33:70.
PubMed
Abstract available

GU H, Hu B, Jiang Y
The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons.
Immunotargets Ther. 2026;15:572970.
PubMed
Abstract available

SUN F, Ge X, Deng L, Wang Y, et al
Research on a method for early diagnosis and progression prediction of cervical cancer based on imaging omics and molecular omics.
Front Oncol. 2026;15:1670852.
PubMed
Abstract available

WANG R, Ning L, Li X, Xu Y, et al
Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer.
Oncol Lett. 2026;31:133.
PubMed
Abstract available

BABATUNDE AN, Aroba OJ, Adeniyi AE, Isiaka SO, et al
Joint segmentation and classification of cervical cells using U-Net and CNN ensemble for early detection of cervical cancer.
Cancer Cell Int. 2026 Feb 25. doi: 10.1186/s12935-026-04234.
PubMed

DIRIE NI, Hassan MM, Ahmed MM, Hassan J, et al
Current Cervical Cancer Status in Resource-Limited Somalia: a Systematic Review of Burden, Screening Findings, and Knowledge Gaps.
J Epidemiol Glob Health. 2026;16:22.
PubMed

WU S, Deng Y, Lepp T, Ask LS, et al
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study.
BMJ. 2026;392:e087326.
PubMed
Abstract available

LI J, Chu C, Zhu L, Du Z, et al
NIR-activated dual-mode oxygen-generating and -delivering nanoplatform for enhanced photodynamic therapy of cervical cancer.
J Mater Chem B. 2026 Feb 25. doi: 10.1039/d5tb02652.
PubMed
Abstract available

ZHAO X, Zhang X, Xu Y, Huang Y, et al
Awareness of HPV, HPV vaccine and associated factors among male junior high school students in Zhejiang Province, China.
Front Public Health. 2026;14:1727798.
PubMed
Abstract available

MAHE L, Cagetti LV, Myxa J, Gonzague-Casabianca L, et al
Dosimetric comparison between manual and inverse optimization methods in high-dose-rate intracavitary/ interstitial cervical cancer brachytherapy for two treatment planning systems.
J Contemp Brachytherapy. 2025;17:400-406.
PubMed
Abstract available

KILAR CR, Bajwa HK, Pifer PM, Beriwal S, et al
Selection of hybrid applicators for adaptive cervical cancer brachytherapy: A practical guide.
J Contemp Brachytherapy. 2025;17:390-399.
PubMed
Abstract available

Erratum to the article: Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer. Authors: Pittaya Dankulchai, Natthakorn Thanamits
J Contemp Brachytherapy. 2025;17:421.
PubMed
Abstract available

YIHEYIS MM, Yeheyis MM, Dessie MG, Anagaw YK, et al
Exploring knowledge, attitudes, and practices on cervical cancer screening and their associated factors among female university students at Debre Markos University, Ethiopia.
Cancer Treat Res Commun. 2026;47:101147.
PubMed
Abstract available

SULEMAN DB, Folorunsho S
Cervical cancer research disparities among African immigrant women in the United States: A systematic review.
Palliat Support Care. 2026;24:e68.
PubMed
Abstract available

FOUCAULT E, Macioce V, Soler M, Pers YM, et al
Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey.
Prev Med Rep. 2026;63:103405.
PubMed
Abstract available

LI F, Ding S, Chen Z, Chen K, et al
Potential of margin reduction for cervical cancer radiotherapy in an online adaptive image-guided workflow.
Phys Imaging Radiat Oncol. 2026;37:100923.
PubMed
Abstract available

DASGUPTA S
Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review.
Cureus. 2026;18:e102126.
PubMed
Abstract available

SUN M, Zhou H, Chen J
Reappraising the clinical value of adjuvant chemoradiotherapy in intermediate-risk cervical cancer: beyond statistical significance.
Int J Surg. 2026;112:5267-5268.
PubMed

CHEN C, Wang S, Liu J, Liao J, et al
Bone marrow function in cervical cancer patients after concurrent chemoradiotherapy using 99mTc-SC SPECT/CT: A cross-sectional retrospective study.
Medicine (Baltimore). 2026;105:e47766.
PubMed
Abstract available

JOSHI M, Rajbanshi M, Rana A, Thapa S, et al
Awareness of cervical cancer, practice of cervical cancer screening and its associated factors among reproductive-aged women in Shankharapur Municipality of Kathmandu district, Nepal: A cross-sectional study.
Medicine (Baltimore). 2026;105:e47729.
PubMed
Abstract available

ADHIAMBO HF, Thomas K, Coe MM, Oluoch L, et al
Applying FRAME-IS to characterize provider-led adaptations to a cervical cancer prevention intervention in Kenya.
Implement Sci Commun. 2026 Feb 24. doi: 10.1186/s43058-026-00883.
PubMed
Abstract available

MOUSAVI-NEJAD S, Rezaei E, Nourizadeh R, Mohammadzadeh Z, et al
The effect of Fogg model-based virtual education on health literacy and stages of behavior change in cervical cancer screening: study protocol for a randomized controlled trial.
Trials. 2026 Feb 24. doi: 10.1186/s13063-026-09574.
PubMed
Abstract available

SHEN T, Ma Y, Wu T, Cao Z, et al
Human papillomavirus16 E7 enhances cell stemness by regulating the APC2/SPIN4/beta-catenin axis in cervical cancer.
Oncogenesis. 2026 Feb 24. doi: 10.1038/s41389-026-00602.
PubMed
Abstract available

SINGH S, Batra N, Mittal S
Emerging nanocarrier platforms in cervical cancer therapy: From molecular targeting to precision nanomedicine.
Nanomedicine. 2026 Feb 21:102913. doi: 10.1016/j.nano.2026.102913.
PubMed
Abstract available

LIU X, Xu T, Wu J, Zhou B, et al
RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe and enhances cisplatin sensitivity.
Biochem Pharmacol. 2026;248:117828.
PubMed
Abstract available

JIANG C, Rosenberg PS, Star J, Bandi P, et al
State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
J Natl Cancer Inst. 2026 Feb 24:djag051. doi: 10.1093.
PubMed
Abstract available

SINGH N, Raj Jalagam V, Somagattu S, Kunwar S, et al
Role of Training Paramedical Staff for Cervical Cancer Screening via Human Papillomavirus Self-Sampling in Remote Mountainous Regions: A Pilot Feasibility Study.
Cureus. 2026;18:e102046.
PubMed
Abstract available

SHARMA V, Gupta N, Leger PD, Ryan WT, et al
Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.
Cureus. 2026;18:e102001.
PubMed
Abstract available

FRANCIS DL
Maternal Cancer Mortality and Orphanhood: A Neglected Global Health and Equity Challenge.
Ann Glob Health. 2026;92:18.
PubMed
Abstract available

ZORRILLA CD, Olmo-Lopez CV, Hernandez Garayua AM, Ibarra J, et al
Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV.
HIV AIDS (Auckl). 2026;18:553851.
PubMed
Abstract available

XIAMUXI H, Deng X, Ablise M, Yan T, et al
A novel pyrrolidine-chalcone derivative exhibits synergistic anti-cervical cancer activity by dual-targeting MDM2-p53 axis and ferroptosis pathway.
Front Pharmacol. 2026;17:1715712.
PubMed
Abstract available

PANDEY P, Hussain A, Khan F
Editorial: Plant bioactive compounds as modulators of oncogenic signalling pathways in cervical cancer.
Front Pharmacol. 2026;17:1788689.
PubMed

ZIDI S, Yacoubi-Loueslati B, Ben Abdelmoumen Mardassi B, Almawi WY, et al
A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.
Front Immunol. 2026;17:1759674.
PubMed
Abstract available

LEE SS, Boitano TKL, Hutchcraft ML, Modesitt SC, et al
#DidYouKnow: Physician engagement online and offline is mission critical to promote accurate and impactful cervical cancer information dissemination.
Gynecol Oncol Rep. 2026;63:102042.
PubMed

TIAN X, Yang H
Development of bioengineered SPIONs using Carica monoica extract: evaluation of antioxidant and anticancer activity of human cervical cancer cells (SiHa).
Open Life Sci. 2026;21:20251258.
PubMed
Abstract available

XUE J, Xiao H, Ren X, Yang Q, et al
Low-molecular-weight metabolites from lactic acid bacteria suppress cervical cancer progression by inhibiting EMT via the Wnt/beta-catenin pathway.
Open Life Sci. 2026;21:20251264.
PubMed
Abstract available

ABUBAKARI AK, Gross J, Adusei-Poku E
Understanding Cervical Cancer Screening Intentions Through the Lens of Care-Seeking Behavior: A Cross-Sectional Study Among Islamic Women in Ghana.
Health Sci Rep. 2026;9:e71827.
PubMed
Abstract available

RIPON RK, Hossain MJ, Prasad NG, Thakkar N, et al
Cervical Cancer, HPV, and HPV Vaccine Knowledge and Willingness to be Vaccinated Among Adolescent Girls in Dhaka, Bangladesh: A Cross-Sectional Study.
Health Sci Rep. 2026;9:e71843.
PubMed
Abstract available

SHI R, Hou W, Gao Y, Sun S, et al
Meta-analysis of risk factors for recurrence in cervical cancer patients following fertility-sparing treatment.
Front Surg. 2026;12:1625067.
PubMed
Abstract available

BERMUDEZ Y, Miller J, Kenney K, Schlueter D, et al
Predictors of Breast Cancer Screening Variability Among National Breast and Cervical Cancer Early Detection Program Awardees: Provider Shortages and Nurse Practitioner Autonomy.
Public Health Rep. 2026 Feb 22:333549261421878. doi: 10.1177/00333549261421878.
PubMed
Abstract available

ALREDHA RDA, Hussein TN, Alzerfi HSR, Haddawi KH, et al
Evaluation of serum Cytokeratin 5 and p63 as non-invasive biomarkers for the diagnosis and staging of cervical cancer: a case-control study.
Clin Transl Oncol. 2026 Feb 21. doi: 10.1007/s12094-026-04238.
PubMed
Abstract available

ANDERER S
At-Home Cervical Cancer Screening Favored by Certain Groups.
JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26399.
PubMed

ZHAO Y, Sha Z, An T, Wang W, et al
TMEM130 promoter hypermethylation predicts tumor cell migration in cervical cancer.
J Mol Histol. 2026;57:83.
PubMed
Abstract available

JIAO Y, He Y, Zhao B, Sha L, et al
The correlation between the systemic immune-inflammation index and relapse and metastasis in cervical squamous cell carcinoma patients over 50 years and older.
BMC Immunol. 2026;27:20.
PubMed
Abstract available

FU X, Zhang Q, Wagner AL, Yao Y, et al
Public Health Impact and Cost-Effectiveness of Routine and Catch-Up Human Papillomavirus Vaccination in Girls and Women in Selected Regions of China: A Model-Based Study.
Pharmacoeconomics. 2026;44:343-357.
PubMed
Abstract available

OLIVA PJ, Ghosh S, Huang F, Wiebe E, et al
Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation.
Brachytherapy. 2026;25:361-372.
PubMed
Abstract available

BOGANI G, Sopracordevole F, Corso G, Vizza E, et al
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes.
Tumori. 2026;112:75-82.
PubMed
Abstract available

NISHIOKA K, Sekiyama K, Shiro R, Tsunoda I, et al
Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis.
Int J Clin Oncol. 2026;31:494-503.
PubMed
Abstract available

HUYNH GT, Li A, Nims L, Seiler J, et al
Intimate Partner Violence and Cervical, Breast, and Colorectal Cancer Screening: Findings from the Washington State Behavioral Risk Factor Surveillance System.
J Womens Health (Larchmt). 2026;35:413-420.
PubMed
Abstract available

GOYAL A, Davey DD, Souers RJ, Roberson J, et al
Practice Patterns Regarding Quality Assurance Measures in Gynecologic Cytology: Survey Results of Laboratories Participating in the 2022 College of American Pathologists PAP Education Program.
Arch Pathol Lab Med. 2025;150:194-201.
PubMed
Abstract available

MILLS AM
Biomarkers in Cervical Squamous Neoplasia: Diagnostic, Prognostic, and Predictive.
Arch Pathol Lab Med. 2025;150:e46-e55.
PubMed
Abstract available

THIEU HH, Le TAH, Lao TD
Meta-analytic and systematic review of the diagnostic value of DNA methylation-based biomarkers in cervical cancer.
Int J Biol Markers. 2026 Mar 5:3936155261419529. doi: 10.1177/03936155261419529.
PubMed
Abstract available

CAO Y, Peng Y, Shen J
ANO6 Confers Paclitaxel Resistance by Targeting Ferroptosis in Cervical Cancer.
Biofactors. 2026;52:e70070.
PubMed
Abstract available

IFEZUOKE TD, Ajah MI, Ajah LO, Ezegwui HU, et al
Chlamydia trachomatis infection seroprevalence among women with normal and abnormal cervical smears and its implication for Nigerian cervical cancer screening.
BMC Infect Dis. 2026 Mar 4. doi: 10.1186/s12879-026-12994.
PubMed
Abstract available

REDDY Y, Pai P, Das I, Nayak S, et al
Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies.
Mol Med. 2026 Mar 4. doi: 10.1186/s10020-026-01446.
PubMed

THASANTHAN L, Hilmi AJ, Rosairo S, Abeysundara HTK, et al
Impact of treatment duration on cervical cancer outcomes with concomitant chemoradiation.
Radiography (Lond). 2026;32:103375.
PubMed
Abstract available

YAMAMURA A, Ukita M, Takemura H, Ishibashi T, et al
Evaluation of neoadjuvant chemotherapy followed by radical hysterectomy in cervical cancer: a single-center study.
Int J Clin Oncol. 2026 Mar 4. doi: 10.1007/s10147-026-02998.
PubMed
Abstract available

EKER K, Sabour Takanlou M, Sabour Takanlou L, Rostamlou A, et al
BET inhibition enhances temozolomide sensitivity in cervical cancer cells through ALDH suppression and epigenetic reprogramming.
Mol Biol Rep. 2026;53:457.
PubMed
Abstract available

SHANG Y, Li K, Liu W, Wang Y, et al
New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis.
Arch Pharm (Weinheim). 2026;359:e70218.
PubMed
Abstract available

ATTIQUE KHAN M, Rauf F, Abbas MJ, Hussain A, et al
A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images.
Technol Cancer Res Treat. 2026;25:15330338261426741.
PubMed
Abstract available

DIEDRICH D, Silva EF, Willig JB, Ruaro TC, et al
The Privileged Scaffold Quinoline in Derivatives With Anticancer Potential Mediated by Late Apoptosis.
Anticancer Res. 2026;46:1475-1487.
PubMed
Abstract available

AL-SHIBLI K, Nguyen DT, Mohammed HAL, Sorbye SW, et al
Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway.
Pathogens. 2026;15:178.
PubMed
Abstract available

STRNADOVA I, Refalo JL, Power R, Basckin C, et al
'Give People More Time and Take the Time to Explain Things Properly': Cervical Screening Experiences of People With Intellectual Disability.
J Appl Res Intellect Disabil. 2026;39:e70206.
PubMed
Abstract available

MARTINEZ B, Jennings P, Strik M, Simon K, et al
Cancer Screening and Barriers to Screening Among Unhoused Individuals in Rhode Island.
R I Med J (2013). 2026;109:41-47.
PubMed
Abstract available

LI L, Wang Y, Liu L, Lou Y, et al
Miniaturized Single-Step Duplex CRISPR Diagnostic Platform for At-Home Molecular Testing of HPV16 and HPV18.
ACS Sens. 2026;11:1117-1128.
PubMed
Abstract available

RINDAL DB, Asche S, Kharbanda E, Michalowicz B, et al
Increasing HPV vaccine promotion by dental providers: A clinical trial protocol.
Contemp Clin Trials. 2026;162:108222.
PubMed
Abstract available

GODDARD Q, Coward S, Seow CH, Bertazzon S, et al
Association of Geography With Screening and Development of Cervical Neoplasia in Those With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Nov 20:izaf249. doi: 10.1093.
PubMed
Abstract available

KIM A, Kim J, Kwak W, Mo K, et al
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
Int J Oncol. 2026;68:57.
PubMed
Abstract available

ZHOU J, Ye W, Ranarisoa SN, Tian L, et al
Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.
Front Immunol. 2026;17:1775409.
PubMed
Abstract available

JI LY, Wang X, Jiao RX, Yang J, et al
Application of Cytokines in Cervical Secretion for High-grade Squamous Intraepithelial Lesion Caused by High-risk Human Papillomavirus Infection.
Biomed Environ Sci. 2026;39:215-222.
PubMed
Abstract available

WILLIAMS DM, Reilly S, Lord T, Ayers K, et al
"Give me the sense that I matter:" Queer women's recommendations for an ideal cervical cancer screening exam and pathways to screening equity.
Womens Health (Lond). 2026;22:17455057261428108.
PubMed
Abstract available

VAN KEER S, van den Helder R, Teblick L, De Smet A, et al
Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
Commun Med (Lond). 2026 Mar 12. doi: 10.1038/s43856-026-01512.
PubMed
Abstract available

LIU X, Vidrine DJ, Sutton SK, Wetter DW, et al
Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.
JAMA Netw Open. 2026;9:e261543.
PubMed
Abstract available

ZHANG L, Quan R, Huang H, Wu M, et al
Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency.
Cancer Biother Radiopharm. 2026 Mar 12:10849785261426657.
PubMed
Abstract available

TAWE L
Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control.
Health Sci Rep. 2026;9:e72038.
PubMed
Abstract available

CHENG Y, Wang J, Wang L, Yan D, et al
Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis.
iScience. 2026;29:114862.
PubMed
Abstract available

LIANG H, Li Q, Liao Y, Huang H, et al
Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line.
Transl Cancer Res. 2026;15:121.
PubMed
Abstract available

KIVUTI-BITOK LW, Mugo CW, Mituki D, Marete C, et al
The effect of school-based educational session on knowledge, attitudes, and beliefs of cervical cancer among adolescents in mixed day high schools in Embu County: a quasi-experimental study.
BMC Public Health. 2026 Mar 11. doi: 10.1186/s12889-026-26675.
PubMed
Abstract available

TANG X, Peng X, Zhang W, Li Z, et al
Ultrasensitive Electrochemiluminescence Nanoprobe for Early Screening and Early Diagnosis of Cervical Cancer.
Anal Chem. 2026 Mar 11. doi: 10.1021/acs.analchem.5c08162.
PubMed
Abstract available

CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
Corrigendum to "Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan" [Taiwan J Obstet Gynecol 64 (2025) 1024-1029].
Taiwan J Obstet Gynecol. 2026;65:399.
PubMed

ZHENG J
Comment on "Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease".
Taiwan J Obstet Gynecol. 2026;65:393.
PubMed

WENG CS, Chen RC, Chen HJ, Tsay JY, et al
Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in Taiwan.
Taiwan J Obstet Gynecol. 2026;65:292-298.
PubMed
Abstract available

WANG CC, Liu SH, Wu MH, Chen JR, et al
Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study.
Taiwan J Obstet Gynecol. 2026;65:247-255.
PubMed
Abstract available

RYU SY, Nam BH, Kim MH, Jang WI, et al
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.
ESMO Open. 2026;11:106102.
PubMed
Abstract available

LIN S, Ouyang Y, Gu H, Chen K, et al
Toward fully automated pre-implantation planning for cervical cancer brachytherapy: a template-guided multi-criteria optimization framework for catheter placement and dose distribution.
Phys Med Biol. 2026 Mar 11. doi: 10.1088/1361-6560.
PubMed
Abstract available

HUA Y, Li Y, Qin H, Huo M, et al
Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.
Nutr Rev. 2026 Mar 11:nuag016. doi: 10.1093.
PubMed
Abstract available

CAKIR Z, Gok Ugur H
The Effect of Motivational Interviewing Based on the COM-B Model on Women's Cervical Cancer Health Beliefs and Participation in Screening: A Single-Blind Randomized Controlled Trial.
Cancer Nurs. 2026 Mar 10. doi: 10.1097/NCC.0000000000001553.
PubMed
Abstract available

GOTTSCHLICH A, Smith LW, Hong Q, Dabee S, et al
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.
JAMA Netw Open. 2026;9:e261304.
PubMed
Abstract available

HUANG J, Li X, Zhuang Y, Zhang Z, et al
Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study.
Cancer Med. 2026;15:e71699.
PubMed
Abstract available

LI G, Lu Z, Yin F, Lu H, et al
High-risk HPV and bacterial STIs in a primary screening population in rural Hainan, China: prevalence, co-infection, and association with cervical abnormalities.
Front Public Health. 2026;14:1773020.
PubMed
Abstract available

GONZALEZ GMN, Inam ME, Msadabwe S, Lee KL, et al
Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia.
Res Sq [Preprint]. 2026 Feb 23:rs.3.rs-8522732. doi: 10.21203/rs.3.rs-8522732.
PubMed
Abstract available

BODHARE T, Bele S, V S, Sheela Kumari K S, et al
An Intervention Study Assessing the Effects of a Breast and Cervical Cancer Health Education Program on Knowledge, Attitudes, and Practices Among Adolescent Female Students in Madurai, South India.
Cureus. 2026;18:e103131.
PubMed
Abstract available

MAYUMI WADA C, Ferrari G, Silveira da Silva L, Pitton M, et al
Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy.
Nanomedicine (Lond). 2026 Mar 11:1-13. doi: 10.1080/17435889.2026.2641148.
PubMed
Abstract available

TRYBUS W, Trybus E, Krol T
Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43011.
PubMed
Abstract available

ALSULAYS BB, Anwer MK, Hatata MN, Raish M, et al
Development of beta-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43779.
PubMed

SUROV A, Hohn AK, Hinnerichs M, Meyer HJ, et al
Associations Between Body Composition and Intratumoural Immune Cells in Patients With Uterine Cervical Cancer.
J Cachexia Sarcopenia Muscle. 2026;17:e70241.
PubMed
Abstract available

IWAHASHI N, Noguchi T, Sakai K, Yahata T, et al
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
Int J Clin Oncol. 2026 Mar 10. doi: 10.1007/s10147-026-03006.
PubMed
Abstract available

ZHANG X, Yin Y, Yang T, Cong Y, et al
HALP outperforms systemic inflammatory biomarkers for prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Biomol Biomed. 2026 Mar 10. doi: 10.17305/bb.2026.13993.
PubMed
Abstract available

TUSAR MTT, Ara R, Farazi R, Roy CR, et al
Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh.
Microbiol Resour Announc. 2026 Mar 10:e0138225. doi: 10.1128/mra.01382.
PubMed
Abstract available

XIAO G, Quan K, Zeng M, Ye Y, et al
Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis.
Technol Cancer Res Treat. 2026;25:15330338261424144.
PubMed
Abstract available

WU H, Yu Y, Wang W, Xu Q, et al
SMC4/SMAD3/NF-kappaB axis drives cervical cancer progression and radioresistance via DNA damage repair and immune modulation.
J Transl Med. 2026 Mar 9. doi: 10.1186/s12967-026-07979.
PubMed
Abstract available

ZOU Z, Huang L, Yin K, Li Y, et al
Effect of immune-related lncRNA BZRAP1-AS1/miR-541-3p and its molecular mechanism in cervical cancer.
World J Surg Oncol. 2026 Mar 9. doi: 10.1186/s12957-026-04270.
PubMed

HU D, Zhao Y, Han M, Qian W, et al
Analysis of factors associated with cervical cancer and precancerous lesions.
Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-025-32215.
PubMed
Abstract available

KONG W, Liu P, Zhang J, Liu Q, et al
Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
Cancer Immunol Immunother. 2026;75:97.
PubMed
Abstract available

PAIVA SANTOS J, Prata R, Serrado MA, Cunha TM, et al
Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
Abdom Radiol (NY). 2026 Mar 9. doi: 10.1007/s00261-026-05415.
PubMed
Abstract available

GUO Y, Li S, Liu T, Chang X, et al
Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.
Int J Med Sci. 2026;23:1015-1032.
PubMed
Abstract available

PAN G, Wang W, Sun Z, Chu R, et al
High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy.
Int J Womens Health. 2026;18:584455.
PubMed
Abstract available

CUI Y, Li Y, Na J, Lu J, et al
Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study.
J Med Biochem. 2025;44:1843-1849.
PubMed
Abstract available

SANCHEZ DIAZ E, Levin G, Fernandes A, Fletcher A, et al
Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review.
Chin Clin Oncol. 2026;15:9.
PubMed
Abstract available

WANG J, Zhang Y, Wang H, Zhang J, et al
Cystathionine-gamma-Lyase/Hydrogen Sulfide Axis Plays a Crucial Role in Promoting the Progression of Cervical Cancer.
J Biochem Mol Toxicol. 2026;40:e70765.
PubMed
Abstract available

KONGWATTANAKUL S, Petroch P, Nimjaroen K, Bawornpatarapakorn S, et al
The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer.
J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.
PubMed
Abstract available

ZHANG G, Zhang X, Li H, Du X, et al
Multi-omic and immune landscapes of HPV-negative versus HPV-positive cervical cancer reveal implications for immunotherapy.
Eur J Surg Oncol. 2026;52:111425.
PubMed
Abstract available

SUSHMA N, C R TP, Y S N, Kaginelli S, et al
Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies.
Asian Pac J Cancer Prev. 2026;27:1091-1098.
PubMed
Abstract available

SRIVASTAVA H, Raghuvanshi S, Bhalla S, Raghuvanshi S, et al
PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472.
Asian Pac J Cancer Prev. 2026;27:1061-1068.
PubMed
Abstract available

FATIHA RA, Ngabdi CK, Azizah JS, Putri BSN, et al
Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.
Asian Pac J Cancer Prev. 2026;27:981-988.
PubMed
Abstract available

MOSAVI JARRAHI A, Rajaie S, Azari S, Karimi F, et al
Standardizing Cost-Effectiveness Evidence for Cancer Prevention: A Case Study Analysis of HPV Vaccination.
Asian Pac J Cancer Prev. 2026;27:789-792.
PubMed
Abstract available

ZHENG L, Zhao G, Zheng L, Zou Y, et al
Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.
Rev Med Virol. 2026;36:e70131.
PubMed
Abstract available

Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).
Trials. 2026;27:195.
PubMed
Abstract available

JIA M, Zeng S, Zou J, Chen H, et al
Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
Cancer Med. 2026;15:e71686.
PubMed
Abstract available

MATOBA Y, Oomori Y, Nishibuchi I, Uegami S, et al
Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70225.
PubMed
Abstract available

CHEN X, Zheng X, Yang Z, Sui F, et al
Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer.
Medicine (Baltimore). 2026;105:e47961.
PubMed
Abstract available

LI Y, Zhang W, Tang L, Zhu Y, et al
Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking.
Medicine (Baltimore). 2026;105:e47993.
PubMed
Abstract available

LI C, Zhao H, Wang J, Liu C, et al
A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation.
Cell Rep. 2026;45:117079.
PubMed
Abstract available

ZHANG J, Zhang Y, Zhang J
BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis.
Iran J Immunol. 2026;23.
PubMed
Abstract available

POY M, Jacquot K, Gross S, Lepiller Q, et al
[Development and distribution of an inter-laboratory comparison test for HPV testing].
Virologie (Montrouge). 2026;30:63-69.
PubMed
Abstract available

CHARPENTIER C, Brousseau J, Jary A, Ferre VM, et al
[Cervical cancer screening: what role for methylation tests?].
Virologie (Montrouge). 2026;30:19-32.
PubMed
Abstract available

DOGHMAN I, Malassigne V, Roucaute L, Azais H, et al
[Advances in screening and follow-up of HPV-related cervical cancer].
Virologie (Montrouge). 2026;30:7-18.
PubMed
Abstract available

ZHAO J, Wang L, Shao N, Qu Y, et al
RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.
Histol Histopathol. 2026 Mar 6:25056. doi: 10.14670.
PubMed
Abstract available

Corrigendum to "Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021".
Cancer Control. 2026;33:10732748261431083.
PubMed

SVINTSITSKY V, Yegorov M, Stakhovsky E, Vitruk Y, et al
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
Exp Oncol. 2026;47:467-477.
PubMed
Abstract available

FASZHOLZ AM, Lozano V, Garda J
Structure, utilization, and screening adherence of a student-run women's health clinic for uninsured Spanish-speaking women: A descriptive analysis.
Womens Health (Lond). 2026;22:17455057261424823.
PubMed
Abstract available

KIRUTHIGA N, Krishnan S, Arulsamy S, Natarajan A, et al
Design and Synthesis of Piperidine Hydroxamate Scaffolds as Novel HDAC Inhibitors with Apoptotic Potential in Human Cervical Cancer Cells.
Med Chem. 2026 Mar 2. doi: 10.2174/0115734064378681251128061500.
PubMed
Abstract available

SHADANG M, Arumugam A, Singh DK, Keshari P, et al
The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer.
Virol J. 2026;23:66.
PubMed
Abstract available

ZHU Y, Liu K, Yang Z, Peng Z, et al
Machine-learning with multiomics for radiotherapy-induced acute rectal toxicities and survival outcome in patients with cervical cancer.
Radiat Oncol. 2026 Mar 5. doi: 10.1186/s13014-026-02814.
PubMed

BENCHEIKH S, Lemriss H, Souiri A, Akachar J, et al
Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development.
RNA Biol. 2026;23:1-14.
PubMed
Abstract available

NGHIEM VTH, Smith S, Shi J, McBrayer A, et al
Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.
J Community Health. 2026 Mar 6. doi: 10.1007/s10900-026-01554.
PubMed
Abstract available

ISLAM O, Assaduzzaman M, Akter S, Fahad N, et al
Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
Sci Rep. 2026 Mar 5. doi: 10.1038/s41598-026-35334.
PubMed

MIAO Z, Yang XL, Zhu JW, Zhou YC, et al
The differences of pelvic lymph node metastasis between squamous cell carcinoma and adenocarcinoma in early-stage cervical cancer patients undergoing radical surgery and adjuvant radiotherapy: a large cohort study.
Ther Adv Med Oncol. 2026;18:17588359261425694.
PubMed
Abstract available

KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Alhassan N, et al
Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.
Health Sci Rep. 2026;9:e71971.
PubMed
Abstract available

ANSARI SN, Kunwar R, Vaidya SA
Immunohistochemical Expression of P16 in Cervical Lesions: An Observational Study.
JNMA J Nepal Med Assoc. 2025;63:823-827.
PubMed
Abstract available

ULMER KK, Sargent MD, Cina KR, Vinson AH, et al
Native American Women's Willingness to Screen for Both Cervical and Colorectal Cancer at Home.
Cancer Med. 2026;15:e71654.
PubMed
Abstract available

BERHANU W, Yigremachew S, Hanson C, Avermark H, et al
A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.
Glob Health Action. 2026;19:2635822.
PubMed
Abstract available

EL-MOGASSABI A, Baiu HS, Hassan NO, Salem EM, et al
Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
Ecancermedicalscience. 2025;19:2047.
PubMed
Abstract available

PUENTE-VALLEJO R, Garcia-Gutierrez A, Jara-Jimenez S, Mosquera-Ruiz MN, et al
Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study.
Ecancermedicalscience. 2025;19:2039.
PubMed
Abstract available

DAS NEVES MAB, Galvao ND, de Lima FCDS, Oliveria JFP, et al
Factors associated with advanced diagnosis of cervical cancer: a hospital-based retrospective study in a state of the Brazilian Legal Amazon.
Ecancermedicalscience. 2025;19:2045.
PubMed
Abstract available

MATHOBELA MN, Chuang TW, Chen PC, Motsa MPS, et al
Prevalence and factors associated with urinary schistosomiasis in women attending cervical cancer screening in Sithobela, Eswatini: A facility-based cross-sectional study.
Helminthologia. 2025;62:296-303.
PubMed
Abstract available

KIM JH, Shim SH, Min KJ, Lee JK, et al
Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk HPV testing in cervical cancer screening.
Obstet Gynecol Sci. 2026 Mar 4. doi: 10.5468/ogs.26066.
PubMed
Abstract available

MURAHWA AT, Dzobo M, Mahenge A, Rantshabeng P, et al
The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects.
Rev Med Virol. 2026;36:e70129.
PubMed
Abstract available

MA X, Xu Z, Chen Y, Jiang F, et al
KIF20A promotes cervical cancer progression by interacting with CLIP1.
Sci Rep. 2026 Mar 3. doi: 10.1038/s41598-026-42883.
PubMed

ZHANG H, Luo X, Jiang J, Zhang C, et al
The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.
NPJ Precis Oncol. 2026 Mar 3. doi: 10.1038/s41698-026-01348.
PubMed
Abstract available

KOVACEVIC IN, Jovanovic A, Ristic J, Milic N, et al
Effect of Organized Cervical Cancer Screening Programs on Incidence and Mortality: A Systematic Review and Meta-analysis.
J Prev (2022). 2026 Mar 4. doi: 10.1007/s10935-026-00908.
PubMed
Abstract available

ZHANG Y, Gao Y, Guan X, Wang E, et al
LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8(+) T-cell suppression.
Cell Mol Life Sci. 2026;83:146.
PubMed
Abstract available

GAO H, Gao Q, Xue L, Lin H, et al
Risk Stratification for Underlying Cervical Intraepithelial Neoplasia Grade (CIN)3+ in Reproductive-Age Women With Biopsy-Confirmed CIN2: Implications for Fertility-Preserving Management.
Cancer Control. 2026;33:10732748261427836.
PubMed
Abstract available

REN W, Cui Z, Wu S, Shen F, et al
A Clinical-DKI Fusion Model for Objective Pretreatment Prediction of Parametrial Invasion in Cervical Cancer.
Acad Radiol. 2026 Mar 2:S1076-6332(26)00108-X. doi: 10.1016/j.acra.2026.
PubMed
Abstract available

LIN J, Wu Q, Liu B, He H, et al
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.
J Gynecol Oncol. 2026 Feb 9. doi: 10.3802/jgo.2026.
PubMed
Abstract available

SSETAALA A, Muwonge I, Namulwa D, Kyakuwa N, et al
Cervical Cancer Screening in Uganda: Determinants of Past Screening and Post-Education Uptake; A Cross-Sectional Survey.
Cancer Control. 2026;33:10732748261427062.
PubMed
Abstract available

JIANG L, Ma S, Du Q, Lv J, et al
Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.
Insights Imaging. 2026;17:64.
PubMed
Abstract available

PENG Y, Wang L, Jin F, Su Z, et al
Application of Manual Lymph Drainage Combined With Complex Decongestive Therapy in Lower Limb Lymphedema After Cervical Cancer Surgery and Its Impact on Quality of Life.
J Obstet Gynaecol Res. 2026;52:e70217.
PubMed
Abstract available

YANG T, Tang M, Xu L, Jiang L, et al
A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification.
Nucleic Acids Res. 2026;54:gkag187.
PubMed
Abstract available

BI Y, Ye Y, Wu X, Cao H, et al
Mechanism of isoleucyl-tRNA synthetase 2 regulating proliferation and apoptosis of cervical cancer cells.
Sci Rep. 2026 Mar 2. doi: 10.1038/s41598-026-41218.
PubMed

HASSINE A, Tisler A, Martel M, Bardou M, et al
Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
Nat Commun. 2026 Mar 2. doi: 10.1038/s41467-026-70050.
PubMed
Abstract available

ZI XJ, Li YL, Chu ZY
Mechanisms of bisphenols-induced cervical cancer: A multidimensional bioinformatics analysis.
Reprod Toxicol. 2026;141:109209.
PubMed
Abstract available

MASSAD LS
Incremental Progress in the Cervical Cancer Screening Revolution.
J Clin Oncol. 2026 Mar 2:JCO2503021. doi: 10.1200/JCO-25-03021.
PubMed

ISAACSON S, Spees LP, Hudgens MG, Pence BW, et al
Racial differences in expected versus actual costs of cervical cancer screening among low-income, under-screened women in North Carolina.
Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. doi: 10.1158/1055-9965.EPI-25-0885
PubMed
Abstract available

ACHARYA GC, Das S, Jasuja A, Debata I, et al
Perception, Practices, and Barriers to Cervical Cancer Screening Among Women in Rural and Urban Slums of Eastern India: A Community-Based Cross-Sectional Study.
Cureus. 2026;18:e102449.
PubMed
Abstract available

ZHOU G, Chen W, Dong X, Guo Q, et al
Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages.
Front Immunol. 2026;17:1611476.
PubMed
Abstract available

ZELINI P, Zavaglio F, Dominioni M, Valsecchi M, et al
Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.
Front Immunol. 2026;16:1733404.
PubMed
Abstract available

KOTIAN N, Reddy Y, Pai P, Sundara BK, et al
A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review.
Cancer Med. 2026;15:e71482.
PubMed
Abstract available

ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
Nanomedicine. 2026 Feb 27:102923. doi: 10.1016/j.nano.2026.102923.
PubMed
Abstract available

MENGISTIE MB, Ayalew WL, Mengistie SK, Gebeyehu AS, et al
Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
BMC Infect Dis. 2026 Feb 28. doi: 10.1186/s12879-026-12976.
PubMed

FREIJOMIL-VAZQUEZ C, Gastaldo D
The Intersecting Effects of Biomedicine and Patriarchy on the Social Lives of Women Undergoing Cervical Cancer Prevention.
Semin Oncol Nurs. 2026 Feb 27:152173. doi: 10.1016/j.soncn.2026.152173.
PubMed
Abstract available

WILLIAMS HR, Kelly D
Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?
Br J Hosp Med (Lond). 2026;87:50727.
PubMed
Abstract available

MASUMOTO S, Tanaka M, Yamamoto K, Hori Y, et al
HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.
Anticancer Res. 2026;46:1733-1739.
PubMed
Abstract available

VEGA C, Leon R, Medina N, Fabelo H, et al
Design and Characterization of a Hyperspectral Colposcope Based on Dual-LCTF VNIR Narrow-Band Illumination.
Sensors (Basel). 2026;26:1255.
PubMed
Abstract available

AZIZAH JS, Ngabdi CK, Fatiha RA, To SW, et al
Physicochemical characterization and anticancer potential of Ficus deltoidea-silver nanoparticles (FD-AgNPs) on HeLa cells: Evidence from apoptosis and proliferation assays.
Biochem Biophys Res Commun. 2026;808:153407.
PubMed
Abstract available

ZHANG J, Wang H, Liu Y, Li Z, et al
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.
J Clin Microbiol. 2026 Feb 19:e0128925. doi: 10.1128/jcm.01289.
PubMed
Abstract available

NITTA N, Sugiyama Y, Sugimura T, Ito T, et al
Clinical-grade autonomous cytopathology through whole-slide edge tomography.
Nature. 2026;651:472-481.
PubMed
Abstract available

JUNIOR DST
Incorporation of HPV-DNA molecular test into the Brazilian healthcare system.
J Cancer Policy. 2026;47:100713.
PubMed
Abstract available

XUE L, Hao S, Sun H, Du L, et al
Spatial clustering of gynecological cancers in China: A countrywide migration-adjusted analysis at the district level.
Cancer Epidemiol. 2026;101:103023.
PubMed
Abstract available

YAN M, Yang Y, Zhao Y, Ma L, et al
Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35-64: A national screening population-based study.
J Infect. 2026;92:106697.
PubMed
Abstract available

LEONARDSEN AL, Englund E, Trope A, Stensrud M, et al
The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons.
BMC Womens Health. 2026;26:141.
PubMed
Abstract available

LI P, Wang H
The diagnostic value of colposcopy in postmenopausal women: a retrospective study.
BMC Womens Health. 2026;26:140.
PubMed
Abstract available

NAVARRO-TORNE A, Aris E, Callegaro A, Benninghoff B, et al
Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.
J Public Health (Oxf). 2026;48:216-227.
PubMed
Abstract available

YIN L, Zhang J, Pang Y, Mou Y, et al
Predictive value of R2 * values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
Clin Radiol. 2026;94:107149.
PubMed
Abstract available

RASHEED A, Shirazi SH, Khan P, Aseere AM, et al
cervical nuclei segmentation through synergic conditional generative adversarial network in cervical smear images.
Comput Biol Chem. 2026;122:108918.
PubMed
Abstract available

HE J, Cheng C, Ding Y, Li N, et al
Design of Therapeutic Vaccines Based on Antigen Epitopes of alpha-9 HPV E6 in Sichuan.
J Immunother. 2026;49:87-97.
PubMed
Abstract available

LEE YS, Yim K, Kim CJ, Kim JH, et al
Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.
Histopathology. 2026;88:970-984.
PubMed
Abstract available

YASUTAKE N, Yokawa Y, Tanaka T, Mishima R, et al
Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.
Histopathology. 2026;88:1003-1015.
PubMed
Abstract available

AZIM MR, Sakib QN, Rahman MM, Islam MS, et al
Economic burden of breast, cervical, and oral cancer in Bangladesh: a cost-of-illness study.
J Cancer Policy. 2026;47:100694.
PubMed
Abstract available

WANG Z, Zhuang L, Liu S, Cao C, et al
Single-Cell and Multiomic Analysis Reveals Neutrophil Heterogeneity and Prognostic Value in Cervical Lesions.
Cancer Sci. 2026;117:597-612.
PubMed
Abstract available

GAO T, Farag M, Agha S, Mobula L, et al
Economic evaluation of the one-dose HPV vaccination program in Nigeria.
J Cancer Policy. 2026;47:100675.
PubMed
Abstract available

DORJI N, Dorji T, Dorjey Y, Yangdon Y, et al
Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward.
J Cancer Policy. 2026;47:100676.
PubMed
Abstract available

NGUYEN-THANH H, Marshall L, Wilson H, Stewart K, et al
Awareness of HPV-related cancers and the HPV vaccination programme in Scotland: a cross-sectional study of gender, deprivation and knowledge gaps.
J Public Health (Oxf). 2026;48:239-248.
PubMed
Abstract available

KAYALI E, Comert GK, Yildirim HT, Toptas T, et al
Nicotinamide Phosphoribosyltransferase (NAMPT) as a New Marker in Cervical Preinvasive Lesions.
Int J Surg Pathol. 2026;34:385-391.
PubMed
Abstract available

STOUT CE, Poiani LTH, Mcglynn A, Enujioke CDRSC, et al
Recommendation for Human Papillomavirus Vaccine after Abnormal Pap Smear in Unvaccinated Active Duty Women.
Mil Med. 2026;191.
PubMed
Abstract available

SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
Anticancer Res. 2023;43:4723-4727.
PubMed
Abstract available

LINDWALL G, Gerlee P
Bayesian inference on the Allee effect in cancer cell line populations using time-lapse microscopy images.
J Theor Biol. 2023;574:111624.
PubMed
Abstract available

SAITO M, Rajesh A, Innes C, van der Griend R, et al
The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
Viruses. 2023;15:1953.
PubMed
Abstract available

CHAIWONGKOT A, Buranapraditkun S, Oranratanaphan S, Chuen-Im T, et al
Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.
Viruses. 2023;15:1802.
PubMed
Abstract available

BOUBLENZA L, Nahet A, Masdoua N, Sadouki N, et al
Prevalence of human papillomavirus infection among women at a gynaecological clinic in Tlemcen, Algeria.
Afr J Reprod Health. 2023;27:56-63.
PubMed
Abstract available

ZHANG H, Liu C, Zhai X, Zhang Q, et al
Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity.
Int Immunopharmacol. 2023;124.
PubMed
Abstract available

HUANG B, Lou Y, Zeng Z, Kan X, et al
A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.
Appl Microbiol Biotechnol. 2023;107:6287-6297.
PubMed
Abstract available

KIHARA K, Kajiyama Y, Kimura Y, Okazaki S, et al
Adult-onset botulism in a Japanese woman with prolonged spore excretion.
J Infect Chemother. 2023;29:1172-1176.
PubMed
Abstract available

ZHANG C, Li X, Zhong L, Wang Y, et al
Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020.
Cancer Epidemiol. 2023;86:102442.
PubMed
Abstract available

PAUTIER P, Genestie C, Gladieff L, Kurtz JE, et al
[Not Available].
Bull Cancer. 2023;110.
PubMed
Abstract available

WANG X, Shi W, Pu X, Hu Y, et al
Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma.
J Cancer Res Clin Oncol. 2023;149:13727-13739.
PubMed
Abstract available

MADZARAC V, Culej D, Muzinic D, Zovko G, et al
Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities.
Neuro Endocrinol Lett. 2023;44:332-335.
PubMed
Abstract available

VILLANUEVA-AGUILAR ME, Rizo-de la Torre LC, Bencomo-Alvarez AE, Gallegos-Arreola MP, et al
Sequence analysis of exons 30 and 31 of LAMA3 gene variants and its association with human papillomavirus infection predisposition: no evidence was found.
Eur Rev Med Pharmacol Sci. 2023;27:6860-6866.
PubMed
Abstract available

ALHARBI SA, Alshammari FD, Humaida MI, Abdalhabib EK, et al
The cytological pattern of cervical smears of a series of Saudi women in one gynecologic center.
Eur Rev Med Pharmacol Sci. 2023;27:6785-6791.
PubMed
Abstract available

THANGARAJAH F, Busshoff J, Salamon J, Pruss MS, et al
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer.
J Cancer Res Clin Oncol. 2023;149:12597-12604.
PubMed
Abstract available

ZHAO J, Liu X, Gao J, Xiao H, et al
Factors Associated with Lesion Recurrence Following Cervical Conization.
Altern Ther Health Med. 2023;29:50-55.
PubMed
Abstract available

VALENZA C, Spada F, Multinu F, Benini L, et al
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Endocr Relat Cancer. 2023;30:e230112.
PubMed
Abstract available

BAHARVAND S, Asghari-Jafarabadi M, Nourizadeh R, Sattarzadeh Jahdi N, et al
The Effect of Decision Aid on Satisfaction With Decision and Anxiety Among Women With Abnormal Cervical Screening Results.
Cancer Nurs. 2023;46:E405-E411.
PubMed
Abstract available

WANG Y, Qiao H, Yu P, Gao W, et al
IKBIP as a prognostic biomarker and immunotherapeutic target regulates the JAK-STAT3 signaling pathway to promote cervical cancer.
J Transl Med. 2026 Mar 20. doi: 10.1186/s12967-026-08015.
PubMed

RADHAKRISHNAN M, Parida BP, Shekhar H, Singh P, et al
Anticancer potential of Curcuma caesia: induction of DNA damage and apoptosis in cervical cancer.
BMC Complement Med Ther. 2026 Mar 21. doi: 10.1186/s12906-026-05351.
PubMed

ZHU Y, Wang H, Zhang B, Chen M, et al
Trends in over- and under-screening for cervical cancer after EMR implementation in rural China.
NPJ Digit Med. 2026 Mar 20. doi: 10.1038/s41746-026-02504.
PubMed
Abstract available

WILLIAMS KP, Todem D, Roman LA, Meghea CI, et al
Kin Keeper(SM) Breast and Cervical Cancer Prevention: An Educational Intervention: A Community-Based Randomized Controlled Trial in Black, Latina, and Arab Women.
J Cancer Educ. 2026 Mar 20. doi: 10.1007/s13187-026-02851.
PubMed

SHEN P, Ye J, Yee HN, Zhang L, et al
Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer.
Virchows Arch. 2026 Mar 20. doi: 10.1007/s00428-026-04477.
PubMed
Abstract available

PARELLADA CI, Bierrenbach AL, Bittencourt Campaner A, Goncalves Queijo R, et al
Assessing the burden of HPV-associated cancers in Brazil: Hospitalization and mortality trends from 2011 to 2019.
Hum Vaccin Immunother. 2026;22:2640760.
PubMed
Abstract available

TOLOSKO J, Beauchesne M
A comparison of the knowledge and practices of cervical cancer prevention between United States and international female college students.
J Am Assoc Nurse Pract. 2026 Mar 20. doi: 10.1097/JXX.0000000000001272.
PubMed
Abstract available

WATANABE K, Di Carlo V, Sugiyama H, Nakamura S, et al
Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).
Jpn J Clin Oncol. 2026;56.
PubMed
Abstract available

XIAO C, Zeng S, Li L, Wang R, et al
Efficacy and safety of immune checkpoint inhibitors combined with chemoradiotherapy in locally advanced cervical cancer: a systematic review and meta-analysis.
Front Pharmacol. 2026;17:1766157.
PubMed
Abstract available

LIU W, Niu Z, Yan Z, Shi L, et al
The Association of EGFL7 Polymorphism and Expression with Cervical Cancer Susceptibility and Pathogenesis.
Int J Gen Med. 2026;19:563592.
PubMed
Abstract available

LUO J, Li G, Ye M, Xu X, et al
RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9.
Oncol Lett. 2026;31:165.
PubMed
Abstract available

XIAO C, Zeng S, Li L, Wang R, et al
Sentinel lymph node biopsy versus lymphadenectomy in early-stage cervical cancer: a meta-analysis of oncologic outcomes and surgical morbidity.
Front Oncol. 2026;16:1765529.
PubMed
Abstract available

YANG W, Lu J, Wang L, Wang H, et al
Dosimetric comparison of MRI-guided and CT-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer.
Front Oncol. 2026;16:1765505.
PubMed
Abstract available

NAVAKANITWORAKUL R, Choochuen P, Hanprasertpong J, Liangpunsakul S, et al
Plasma proteomic biomarkers for predicting chemoradiation response in locally advanced cervical cancer.
BMC Womens Health. 2026 Mar 19. doi: 10.1186/s12905-026-04410.
PubMed

GUILLAUME D, Perrin N, Alcaide ML, Amedee LM, et al
Development and Psychometric Testing of a Scale Evaluating Traditional Health Practices for Cervical Cancer Prevention Among Haitian Migrant Women.
Psychooncology. 2026;35:e70433.
PubMed
Abstract available

XIONG H, Shi X, Li L, Yang Q, et al
Emodin exerts antitumor effects in cervical cancer cells by reprogramming phospholipid metabolism through modulation of H3K27ac and H3K27me3.
Int J Biol Macromol. 2026 Mar 17:151454. doi: 10.1016/j.ijbiomac.2026.151454.
PubMed
Abstract available

JACOBS C, DeMoulin D, Kayamba V, Sudenga S, et al
Stigma and Its Association With Social Support and Quality of Life Among Patients With Cervical Cancer in Zambia.
JCO Glob Oncol. 2026;12:e2500593.
PubMed
Abstract available

NDLELA MG, Vilakati LN, Williams V, Ginindza NM, et al
Cervical cancer screening adherence following initial HIV testing in Eswatini.
HIV Med. 2026 Mar 19. doi: 10.1111/hiv.70227.
PubMed
Abstract available

CHAN HCC, Bhoora S, Zhou E, Marais S, et al
Analysis of Reactive Oxygen Species-Induced Cellular Damage in Cervical Cancer.
Curr Protoc. 2026;6:e70328.
PubMed
Abstract available

HOMENTA C, Kurniadi A, Winarno GNA, Santiana L, et al
Neoadjuvant Paclitaxel-Carboplatin Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer.
Int J Womens Health. 2026;18:580324.
PubMed
Abstract available

PUROBI SM, Ashrafunnesa, Begum SA, Mahmud T, et al
HPV DNA Test Alone and HPV DNA Test Combined with VIA as Screening Test for Cervical Cancer.
J Pharm Bioallied Sci. 2026;18.
PubMed
Abstract available

OGUNLAJA AO, Adeleke OT, Ughonu PC, Oyelami MO, et al
A multi-magnification digital colposcopy image datasets for cervical cancer screening in Nigeria.
Data Brief. 2026;65:112633.
PubMed
Abstract available

NEZAMABADI FARAHANI L, Kazemnejad A, Afrasiabi M, Tapak L, et al
In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach.
Arch Iran Med. 2025;28:677-686.
PubMed
Abstract available

BOLTEN K, Burns H, Scott C, Smart K, et al
Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients.
J Womens Health (Larchmt). 2026 Mar 18:15409996261433761.
PubMed
Abstract available

EL-ZEIN M, Kassam P, Alhamlan F, Zafar N, et al
Toward cervical cancer prevention and elimination in the Eastern Mediterranean Region: Current landscape and opportunities for evidence-based action.
Prev Med. 2026 Mar 16:108549. doi: 10.1016/j.ypmed.2026.108549.
PubMed
Abstract available

ABREU M, Mota ME, Oliveira DMA, Medeiros YL, et al
Inequalities in time to cancer treatment initiation over a decade in Brazil.
Rev Saude Publica. 2026;60:e12.
PubMed
Abstract available

KURBAN R, Pan J, Amar T, Bo X, et al
The eIF3a/m6A/ENO1 axis orchestrates glycolytic reprogramming and cell growth in cervical cancer.
J Bioenerg Biomembr. 2026 Mar 18. doi: 10.1007/s10863-026-10096.
PubMed

BAUTISTA J, Cortinas Sardi P, Paguay-Caisabanda I, Gancino-Guevara K, et al
Integrating microbiome insights into cervical cancer.
Front Med (Lausanne). 2026;13:1766052.
PubMed
Abstract available

AMATULLAH M, Begum SA, Mahmud T, Nahar K, et al
Association of Preoperative Controlling Nutritional Status (CONUT) Score with the Staging of Cervical Cancer.
J Pharm Bioallied Sci. 2025;17.
PubMed
Abstract available

KUMAR N, Dash M, Lal P, Kotian T, et al
Incidence and Impact of HPV Vaccination on Cervical Cancer: A Data Base Research.
J Pharm Bioallied Sci. 2025;17.
PubMed
Abstract available

WANGSATIDTONGBAI P, Buhachat R, Thiangphak E
Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer.
Obstet Gynecol Sci. 2026 Mar 17. doi: 10.5468/ogs.26032.
PubMed
Abstract available

BARAL S, Silwal SR, Bhattarai N, Lamichhane D, et al
Evaluation of Quality Indicators for Radiation Therapy of Cervical Cancer: Experience From a Tertiary Cancer Center in Nepal.
JCO Glob Oncol. 2026;12:e2500435.
PubMed
Abstract available

CILLA S, Medici F, Ferioli M, Arcelli A, et al
Unsupervised clustering analysis unravels the role of systemic inflammatory indices in the prognosis of patients with locally advanced cervical cancer treated with chemoradiation.
Strahlenther Onkol. 2026 Mar 17. doi: 10.1007/s00066-026-02513.
PubMed
Abstract available

CHANDA S, Kumar N, Agarwal A, Pradhan A, et al
Fluorescence Mueller matrix imaging of the stromal region in unstained cervical tissue sections: quantitative categorization of CIN grades.
Appl Opt. 2025;64:8840-8848.
PubMed
Abstract available

JANOVSKA N, Rob L, Pichlik T, Sehnal B, et al
Cervical cancer screening in the European context - from cytology to primary HPV testing.
Ceska Gynekol. 2026;91:69-76.
PubMed
Abstract available

ROBOVA K, Pichlik T, Rob L, Robova H, et al
Age-specific incidence and mortality of cervical cancer in the Czech Republic - analysis of nationwide data and data from a gynecologic oncology center.
Ceska Gynekol. 2026;91:61-68.
PubMed
Abstract available

ROKOS T, Kudela E, Pribulova T, Holubekova V, et al
Cytological versus histological results in ASCUS cervical dysplasia - a retrospective study.
Ceska Gynekol. 2026;91:11-15.
PubMed
Abstract available

KOZACHEK CC, Btoush R
Cervical Cancer Risk: Sexual and Screening Behaviors Among Middle Eastern College Women in the United States.
J Transcult Nurs. 2026 Mar 17:10436596261430095. doi: 10.1177/10436596261430095.
PubMed
Abstract available

DELGADO LOPEZ D, Pozo-Palacios J, Vergara Quezada J, Caulier-Cisterna R, et al
Factors Associated with Under- and Over-Screening for Cervical Cancer in Rural Areas of Cuenca, Ecuador.
J Prim Care Community Health. 2026;17:21501319251414282.
PubMed
Abstract available

WEI X, Su L, Chen R, He T, et al
Unveiling TNFRSF19: a novel tumor suppressor targeting endoplasmic reticulum stress and LGR5/Wnt/beta-catenin in cervical cancer.
Hum Cell. 2026;39:53.
PubMed
Abstract available

GAO W, Wang C, Jia J, Li Y, et al
Evaluation and comparison of TCR repertoire differences between patients with cervical cancer and healthy individuals.
Sci China Life Sci. 2026 Mar 10. doi: 10.1007/s11427-025-3221.
PubMed

Self-Collected Samples for Cervical Cancer Screening: What You Need to Know.
Am Fam Physician. 2026;113:online.
PubMed

WISER A MD, Quinlan JD MD
Cervical Cancer Screening.
Am Fam Physician. 2026;113:137-144.
PubMed
Abstract available

CAI C, Richards-McDonald L, Trimble CL
Barriers to Cervical Cancer Screening Follow-up: A Study of an Inpatient Screening Program.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000943.
PubMed
Abstract available

JI L, Zhou X, Yao L
Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: A Qualitative Study Based the Macro Model of Health System.
J Med Internet Res. 2026 Feb 23. doi: 10.2196/75372.
PubMed
Abstract available

HE C, Li F, He M, Li J, et al
The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis.
Acta Oncol. 2026;65:213-227.
PubMed
Abstract available

DANIELS K, Khan MJ, Gaffikin L, Gonzalez Montoya RA, et al
Integrating Cervical Cancer Screening Into Pre-existing, Low-resource Mexican-US Border Clinics.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000940.
PubMed
Abstract available

KETCH PW, Boitano TKL, Longinos NA, Swann SA, et al
Physician Perspectives on the Transition to Primary Human Papillomavirus Testing for Cervical Cancer Screening.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000942.
PubMed
Abstract available

MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
Reply to "Urine-based detection of HPV for cervical cancer screening: towards clinical implementation".
J Clin Microbiol. 2026 Mar 16:e0016226. doi: 10.1128/jcm.00162.
PubMed

LI G, Lamsisi M, Chenafi S, Moniod L, et al
Urine-based detection of HPV for cervical cancer screening: towards clinical implementation.
J Clin Microbiol. 2026 Mar 16:e0013326. doi: 10.1128/jcm.00133.
PubMed

DORJI C, Dorji N, Dechen S, Pradhan G, et al
Incidental finding of a sewing needle in the buttock of a woman with cervical cancer: how did we manage it?
Int J Surg Case Rep. 2026;138:808-813.
PubMed
Abstract available

YANG X, Zhao B, Yu G, He Z, et al
Dosimetric Comparison of Intracavitary Versus Combined Intracavitary-Interstitial Image-Guided Brachytherapy in Locally Advanced Cervical Cancer.
Dose Response. 2026;24:15593258261430575.
PubMed
Abstract available

BELCHER NL
Clinician Education and Workflow Tools to Improve Access to Recurrent and Metastatic Cervical Cancer Treatment.
Cureus. 2026;18:e103426.
PubMed
Abstract available

KIM JH, Shim SH, Min KJ, Lee JK, et al
Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology.
J Gynecol Oncol. 2026 Mar 1. doi: 10.3802/jgo.2026.
PubMed
Abstract available

HALDER S, Singh S, Sood R, Mathur S, et al
Synchronous Presentation of Gastric-Type Adenocarcinoma In Situ of Cervix and Vagina in a Young Adult Female: A Precursor Seldom Seen.
J Obstet Gynaecol Res. 2026;52:e70249.
PubMed
Abstract available

MUTISYA R, Gitonga E, Maundu MM, Iseme-Ondiek R, et al
Implementation and acceptability of a community based intervention for cervical cancer screening amongst women of reproductive age in Kiambu County, Kenya.
BMC Res Notes. 2026 Mar 15. doi: 10.1186/s13104-026-07710.
PubMed

LU Z, Li Y, Luo D, Chen C, et al
Impact of bladder volume precision control on setup errors and dosimetry in intensity-modulated radiation therapy for cervical cancer.
J Egypt Natl Canc Inst. 2026;38:9.
PubMed

QI M, Tian C, Di X, Ma J, et al
Trends and regional patterns of cervical cancer incidence by histological subtypes: A Chinese population-based analysis from cancer registry data.
Cancer Epidemiol. 2026;102:103047.
PubMed
Abstract available

BELHADJ A, Boumeddane YK, Meddah D, Sahraoui T, et al
Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives.
Tunis Med. 2025;103:1098-1103.
PubMed
Abstract available

LAGU IJL, Letoluo R, Kamau SW, Kuria JM, et al
Antiproliferative activity, phytochemistry, network pharmacology, molecular docking and gene expression analysis of Maerua edulis extracts against human cervical cancer cell line.
BMC Complement Med Ther. 2026 Mar 14. doi: 10.1186/s12906-026-05321.
PubMed
Abstract available

SUN R, Gong H, Zhao R, Lv H, et al
SOX4 induces cisplatin resistance in cervical cancer cells by inhibiting aerobic glycolysis.
Cell Death Discov. 2026 Mar 14. doi: 10.1038/s41420-026-02954.
PubMed
Abstract available

CHEN Y, Zhong L, Chen J, Li X, et al
Corrigendum to "Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting" [Int. J. Biol. Macromol. 336 (2026) 149419].
Int J Biol Macromol. 2026 Mar 13:151353. doi: 10.1016/j.ijbiomac.2026.151353.
PubMed

OSORNO-VALENCIA D, Montoya-Gomez A, Sevilla-Sanchez MJ, Burbano-Guerrero N, et al
Lansbermin-I, a disintegrin from Porthidium lansbergii lansbergii venom as a potential anticancer prototype: In vitro and in silico effects on cervical cancer cells.
Toxicon. 2026;276:109063.
PubMed
Abstract available

SCHNALL R, Ozoria Ramirez S, Halpern M, Kuhn L, et al
Factors Related To Improving the Quality of Cervical Cancer Screening for Women Living with HIV in La Romana, Dominican Republic: A Qualitative Descriptive Study.
AIDS Behav. 2026 Mar 14. doi: 10.1007/s10461-026-05074.
PubMed
Abstract available

JIA X, Da X, Shi J, Duan R, et al
HPV vaccine awareness and uptake among women attending cervical screening in health-resource-limited areas of China: A multicenter cross-sectional study.
Hum Vaccin Immunother. 2026;22:2644020.
PubMed
Abstract available

OZDEMIR S, Caglayan R
Health education on HPV vaccination and cervical cancer prevention: A randomised controlled trial on knowledge, attitudes, beliefs, and behaviours.
J Pak Med Assoc. 2026;76:140-150.
PubMed
Abstract available

MARTIN RJ, Arya M, Ramakrishnan J, Menachery SJ, et al
Machine Vision Approaches for Cervical Cancer Screening Using Pap-Smear Images: A Systematic Review.
Curr Cancer Drug Targets. 2026 Mar 11. doi: 10.2174/0115680096398033251128082310
PubMed
Abstract available

SOHEL HI, Zahan UF, Ishikawa M, Kanno K, et al
Integrated Molecular and Functional Characterization of Cervical Small-Cell Neuroendocrine Carcinoma Using a 3D Organoid Model.
Int J Mol Sci. 2026;27:2393.
PubMed
Abstract available

CHANG Y, Kay N, Chiu LC, Huang CI, et al
Incidence Trends and Geographic Variations of Corpus Uteri and Cervical Cancer in Taiwan, 1995-2022: A Population-Based Study.
Cancers (Basel). 2026;18:881.
PubMed
Abstract available

LIU J, Zhu Y, Liu K, Deng D, et al
Comprehensive Comparison of Surgery Followed by Radiotherapy and Radical Radiotherapy for Cervical Cancer: A Multicenter Retrospective Propensity-Score-Matched Analysis.
Cancers (Basel). 2026;18:865.
PubMed
Abstract available

SHENG Y, Wujcik HE, Wakefield MR, Fang Y, et al
Poseidon's Trident: "Divine" Intervention in Cervical Cancer Through Chemoradiation, Immunotherapy, and Antibody-Drug Conjugates.
Cancers (Basel). 2026;18:774.
PubMed
Abstract available

ASAKITOGUM DA, Ohene LA, Aziato L
Women's experiences with traditional medicine for the treatment of cervical cancer: a qualitative study.
BMC Complement Med Ther. 2026 Mar 13. doi: 10.1186/s12906-026-05344.
PubMed

OSAFO KS, Zhang Y, Obiri-Yeboah D, Sun B, et al
Advancing the elimination of cervical cancer across Africa.
Nat Commun. 2026 Mar 13. doi: 10.1038/s41467-026-70450.
PubMed
Abstract available

SUN Y, Yang H, Wang J, Lou H, et al
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
Nat Commun. 2026 Mar 14. doi: 10.1038/s41467-026-69965.
PubMed
Abstract available

DUN C, Su Y, Basu P, Zhao X, et al
Temporal trends in cervical cancer incidence and mortality in economically emerging countries, 1992-2021: an age-period-cohort analysis.
BMJ Glob Health. 2026;11:e018569.
PubMed
Abstract available

YANG D, Liu J, Gao Y, Guan X, et al
RNF125 promotes CD8 T cell-mediated anticancer immunity and suppresses the malignant phenotype of cervical cancer.
Mol Cell Biochem. 2026 Mar 13. doi: 10.1007/s11010-026-05507.
PubMed
Abstract available

LIXIA H, Liangcheng X, Tian T, Dongmei Z, et al
Prevalence of high-risk human papillomavirus among women with different HPV-vaccination status in Sichuan, China.
Vaccine. 2026;77:128387.
PubMed
Abstract available

CHEN CC, Hsiao KY, Lu SC, Bai CH, et al
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse.
J Low Genit Tract Dis. 2026;30:100-109.
PubMed
Abstract available

LU Y, Tang C, Xu S, Hussain I, et al
Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment.
Vaccine. 2026;76:128307.
PubMed
Abstract available

UYSAL O, Yalcin Y, Cakar MK, Ozerkan K, et al
The Effect of Cervical Blockade in LEEP Procedures Performed Under General Anesthesia: A Randomized Controlled Trial.
J Low Genit Tract Dis. 2026;30:132-139.
PubMed
Abstract available

BOOTH BB, Khare SK, Blanes-Vidal V, Bor P, et al
Higher Diagnostic Accuracy of an AI Model for Colposcopy Compared With Conventional and Digital Colposcopic Evaluation.
J Low Genit Tract Dis. 2026;30:118-123.
PubMed
Abstract available

ROTH MT, Torous VF
Cytomorphologic alterations, histologic correlates, and clinical importance of pap test evaluation in intrauterine device users.
J Am Soc Cytopathol. 2026;15:133-143.
PubMed
Abstract available

MAINA J, Benseler A, Dzyubak O, Bouchard-Fortier G, et al
Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix Brachytherapy.
Pract Radiat Oncol. 2026;16:103-106.
PubMed
Abstract available

GE Y, Wang X, Zhang Y, Ma L, et al
Comparative Survival Outcomes of Total Hysterectomy Versus Radical Hysterectomy in Gastric-Type Endocervical Adenocarcinoma: A SEER Database Analysis.
J Obstet Gynaecol Can. 2026;48:103156.
PubMed
Abstract available

QIU Y, Hu C, Zhao S, Chen D, et al
ROS-Responsive Nano-Encapsulated Selenium Targeting Cervical Cancer Cell via PI3K/AKT Signaling Pathway.
Int J Nanomedicine. 2026;21:558115.
PubMed
Abstract available

WANG M, Cao Y, Zhu M, Zhao P, et al
An auxiliary diagnosis model for the pathological classification of cervical cancer based on radiomics biomarkers.
Front Genet. 2026;17:1685927.
PubMed
Abstract available

PIERSON RN, Gupta SA, Zhang M, Kaiser LC, et al
QUANTIFYING GLYCOGEN AND LIPID DROPLET SYNTHESIS IN OVARIAN AND CERVICAL CANCER CELLS USING DEUTERATED RAMAN PROBES WITH STIMULATED RAMAN SCATTERING MICROSCOPY.
bioRxiv [Preprint]. 2026 Mar 18:2026.03.16.712189.
PubMed
Abstract available

SAVAS LS, Heredia NI, Huyan Y, Coan S, et al
A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults.
Front Oncol. 2026;16:1687113.
PubMed
Abstract available

PAUDEL YR, Xu L, Onobrakpor SI, Dampf H, et al
Reduced age-wise disparity in estimated cervical cancer screening participation rates after applying hysterectomy correction: a population-based cross-sectional study.
BMC Womens Health. 2026 Mar 26. doi: 10.1186/s12905-026-04414.
PubMed

ASARE M, Sam-Agudu NA, Cudjoe O, Frueh E, et al
HOme-based self-sampling for cervical cancer prevention education among women living with HIV in Ghana (HOPE-inG): study protocol for a cluster-randomized type 2 hybrid effectiveness implementation trial.
BMC Public Health. 2026 Mar 27. doi: 10.1186/s12889-026-26505.
PubMed
Abstract available

SAKTHIVEL M, Ramalingam A, Chadwick J, Kriina M, et al
Cervical cancer screening coverage and care cascade in Tamil Nadu, India, based on a community-based cross-sectional survey.
Sci Rep. 2026 Mar 26. doi: 10.1038/s41598-026-45005.
PubMed

ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
Corrigendum to "DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles" [Nanomed Nanotechnol Biol Med 10.1016/j.nano.2016.11.019 [pubmed: 27979747 issn: 1549-9634]].
Nanomedicine. 2026 Mar 25:102932. doi: 10.1016/j.nano.2026.102932.
PubMed

LIM JH, Yeap LL, Saw PS, Ng KY, et al
Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.
Prev Med. 2026 Mar 24:108564. doi: 10.1016/j.ypmed.2026.108564.
PubMed
Abstract available

SAPKOTA S, Pandit S, Bhandari J, Adhikari A, et al
Stage Migration and Validity of the International Federation of Gynecology and Obstetrics (FIGO) 2018 Staging System for Cervical Cancer: A Retrospective Cohort Study From a Tertiary Cancer Center in Nepal.
Clin Med Insights Oncol. 2026;20:11795549261434986.
PubMed
Abstract available

JI L, Wu J, Zhou Y, Pu X, et al
A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases.
Front Cell Infect Microbiol. 2026;16:1734088.
PubMed
Abstract available

WANG L, Zhang M, Li Y, Lei R, et al
Serum PLAC1 levels for differential diagnosis between cervical intraepithelial neoplasia and invasive cervical cancer: a prospective observational study.
Cytotechnology. 2026;78:70.
PubMed
Abstract available

GOPALANI SV, Qin J, Wu M, Senkomago V, et al
Declines in cervical cancer incidence among young women in the United States.
J Natl Cancer Inst. 2026 Mar 25:djaf375. doi: 10.1093.
PubMed
Abstract available

LI J, Li F, Meng X, Yang Z, et al
FAM83D facilitates EMT and metastasis of cervical cancer via interaction with GSK3beta and inactivation of GSK3beta/stabilization of Snail signaling.
Biol Direct. 2026 Mar 25. doi: 10.1186/s13062-026-00761.
PubMed

ROSENBERG K
One dose of HPV vaccine is noninferior to two doses.
Am J Nurs. 2026;126:62.
PubMed
Abstract available

LI T, Ma J, Pang C, Wang Y, et al
Head-to-head Comparison of Fibroblast Activation Protein Inhibitors and (18)F-fluorodeoxyglucose in Cervical Cancer: A Systematic Review and Meta-analysis.
Acad Radiol. 2026 Mar 24:S1076-6332(26)00170-4. doi: 10.1016/j.acra.2026.
PubMed
Abstract available

SIGOVANA K, Nomatshila SC, Chitha W, Mabunda SA, et al
Protocol for exploring health promoter-led mental wellness initiatives for early prevention, screening and quality of life in patients with cervical cancer of rural Eastern Cape, South Africa: a mixed-methods study.
BMJ Open. 2026;16:e104827.
PubMed
Abstract available

WENG Z, Huang W, Wu Y, Xiu X, et al
Machine learning-directed massively parallel programmable nucleic acid amplification.
Sci Adv. 2026;12:eaec9175.
PubMed
Abstract available

HAN C, Zhao Y, Yang X, Sun F, et al
Integrated analysis and functional validation of PEG3, SYNPO2, and DCN as regulators of tumor suppression and cellular stress in cervical cancer.
Immunol Res. 2026;74:31.
PubMed

PUNZIANO C, Minopoli G, Romano S, Marrone L, et al
Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation.
Mol Oncol. 2026 Mar 25. doi: 10.1002/1878-0261.70216.
PubMed
Abstract available

LI W, Ran R, Li J
Single-cell and multi-omics analyses identify CAMP-associated neutrophil remodeling during radiochemotherapy in cervical cancer.
Front Cell Dev Biol. 2026;14:1773562.
PubMed
Abstract available

LU C, Chen N, Sun H, Wang C, et al
Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Randomized Controlled Trial.
J Pain Res. 2026;19:598960.
PubMed
Abstract available

MOHAMAD B, Saifo M
Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria.
Ecancermedicalscience. 2026;20:2066.
PubMed
Abstract available

CHEN C, Guo L, Li S, Sun J, et al
Predicting complete response to concurrent chemoradiotherapy in locally advanced cervical squamous cell carcinoma using multi-sequence MRI data and a 2.5D deep learning algorithm integrated with crossformer model.
Sci Prog. 2026;109:368504261437172.
PubMed
Abstract available

SONODA K, Chrusciel T, Gebauer SC, Bello JK, et al
Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study.
Popul Health Manag. 2026 Mar 24:19427891261434371.
PubMed
Abstract available

BILGAIYAN S, Swain A, Das S, Medha, et al
Advanced analysis and detection of cervical cancer using NASNetLarge.
Sci Rep. 2026 Mar 24. doi: 10.1038/s41598-026-38341.
PubMed

SU Y, Zhang J, Wu H, Zhang Y, et al
NCBP2 Regulates PGAM5-Mediated Mitophagy Via KIF23 Alternative Splicing To Promote Cervical Cancer ProgressionRun Title: NCBP2 Promotes Cervical Cancer Via Mitophagy.
Appl Biochem Biotechnol. 2026 Mar 24. doi: 10.1007/s12010-026-05607.
PubMed
Abstract available

ANTONY EDWIN RODRIGUES F, Krishnan D, Abbas HH, Raj MJM, et al
Transcriptome sequencing (RNA-Seq) reveals non-coding pseudogene CDC27P9 role in cervical cancer.
Apoptosis. 2026;31:111.
PubMed
Abstract available

ANDRADE MB, Pilger TL, Candido Dos Reis FJ
Prevalence of Pelvic Floor Dysfunction in Women with Cervical Cancer: A Cross-Sectional Study.
Int Urogynecol J. 2026 Mar 24. doi: 10.1007/s00192-026-06582.
PubMed
Abstract available

WU R, Kalima M, Msadabwe S, Mwaba C, et al
Changes in cervical cancer stage at diagnosis in Zambia over 15 years.
Cancer Causes Control. 2026;37:65.
PubMed
Abstract available

YANG H, Li Y, Xiao Z, Kuang M, et al
Mechanism of HAND2 Regulating Glycolytic Metabolism and Metastasis Through TLR4/NOX2/DUOX2 Signaling Axis in Cervical Cancer.
Mol Carcinog. 2026 Mar 23. doi: 10.1002/mc.70082.
PubMed
Abstract available

MALFATTI MC, Gualandi N, Tell G, Antoniali G, et al
The cooperative regulation of miR-221 by APE1 and AUF1 impacts p27(Kip1) defining a miR signature relevant for cervical cancer.
FEBS Open Bio. 2026 Mar 23. doi: 10.1002/2211-5463.70190.
PubMed
Abstract available

ABUDOUKADE A, Hong S, Jiang M, Yin D, et al
Predictive value of the systemic immune-inflammation index combined with the prognostic nutritional index for postoperative recurrence in early-stage cervical cancer: evidence from a multicenter cohort study.
Front Oncol. 2026;16:1792373.
PubMed
Abstract available

YANG Q, Bai D, Bao L, Liang L, et al
Case Report: A case of right ventricular metastasis from cervical cancer presenting with thrombocytopenia: the role of echocardiography and myocardial contrast echocardiography.
Front Oncol. 2026;16:1774949.
PubMed
Abstract available

LI Y, Liu Z, Jin H
Mechanism of N6-methyladenosine (m6A)-mediated upregulation of LINC00958 in the growth of cervical cancer.
Front Oncol. 2026;16:1663904.
PubMed
Abstract available

ZHOU L, Sun C, Diao P, Wang J, et al
Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
Front Immunol. 2026;17:1780791.
PubMed
Abstract available

HE Z, Lai J, Lin W, Lu K, et al
Prognostic value of the lactate dehydrogenase-to-albumin ratio (LAR) combined with clinicopathological indicators for predicting outcomes in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study and nom
Am J Cancer Res. 2026;16:470-495.
PubMed
Abstract available

XU B, Liu J, Li H, Zhang T, et al
Concordance and acceptability of a novel human papillomavirus self-collection tool for cervical cancer screening in economically developed regions: a prospective cohort study in Shanghai, China.
Front Med (Lausanne). 2026;13:1760186.
PubMed
Abstract available

BENITEZ MAJANO S, Katz N, Urrutia S, Caixeta R, et al
Accelerating the elimination of cervical cancer: cross-sectional examination of cancer prevention and control in Latin America and the Caribbean.
Lancet Reg Health Am. 2026;55:101398.
PubMed
Abstract available

SHAMSUNDER S, Digumarti L, Nayak B, Dasari V, et al
Bringing Cervical Cancer Screening Closer to Women: Feasibility of Artificial Intelligence and Remote Assessment in Primary Health Care.
Int J Public Health. 2026;71:1609094.
PubMed
Abstract available

MAO Y, Xing N, Sun W, Bao X, et al
Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-beta bifunctional fusion protein in recurrent cervical cancer.
Hum Vaccin Immunother. 2026;22:2647560.
PubMed
Abstract available

A clinical review of cervical cancer.
Nursing. 2026;56:27-28.
PubMed

PULLEN RL JR, Ritchie S
A clinical review of cervical cancer.
Nursing. 2026;56:17-27.
PubMed
Abstract available

HAGOS MT, Suutala A, Bychkov D, Kucukel H, et al
Validation of conformal prediction in cervical atypia classification.
Sci Rep. 2026;16:9649.
PubMed
Abstract available

XIAO JJ, Cong Q, Sui L
[Correlation study of blood lipid indexes and body mass index with clinical characteristics of cervical squamous cell carcinoma].
Zhonghua Fu Chan Ke Za Zhi. 2026;61:236-245.
PubMed
Abstract available

MA X, Jiang F, Chen Y, Cao Y, et al
RNF2 facilitates the progression of cervical cancer through the degradation of LATS1.
Life Sci. 2026 Mar 20:124340. doi: 10.1016/j.lfs.2026.124340.
PubMed
Abstract available

HASE EA, Ferreira HB, Peres SV, Sadalla JC, et al
Cervical cancer during pregnancy: Management and maternal and perinatal outcomes.
Cancer Treat Res Commun. 2026;47:101185.
PubMed
Abstract available

WANG J, Li Z, He Y, Chu Y, et al
Corrigendum to "Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development" [Tissue Cell 93 (2025) 102713].
Tissue Cell. 2026 Mar 20:103478. doi: 10.1016/j.tice.2026.103478.
PubMed

PILLAI S, Wynter K, Galbally M
A Systematic Review of Women's Cancer Screening and Mortality in Women with Severe Mental Illness.
Schizophr Bull. 2026;52:sbaf254.
PubMed
Abstract available

MECOLI CA, Viswanathan AN, Rosen A, Casciola-Rosen L, et al
Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: A case report.
Mod Rheumatol Case Rep. 2026;10:rxag016.
PubMed
Abstract available

LIM H, Kim SI, Min KJ, Lee JK, et al
Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations.
J Gynecol Oncol. 2026;37:e71.
PubMed
Abstract available

HERRERA DJ, Huber L, Ferrari A, Van Hal G, et al
Barriers to and facilitators of cancer prevention services for transgender and gender-diverse people: A systematic review.
Prev Med. 2026;206:108544.
PubMed
Abstract available

KAMOLRATANAKUL S, Niyom SL, Isarankura N, Ruengprasertkit C, et al
Long-term effectiveness of at least one dose of human papillomavirus vaccine in adolescents: A test-negative case-control study.
Int J Infect Dis. 2026;165:108489.
PubMed
Abstract available

LIU Y, Dai W, Du H, Jiang X, et al
Evidence for triaging HPV-positive women using viral load: data from two large cohort-screening projects in different regions of China.
Int J Infect Dis. 2026;165:108462.
PubMed
Abstract available

GOMEZ CHEREY JF, Noemi Payalef S, Chen X, Paula Reyes A, et al
Prevalence of hr-HPV types and their association with bacterial vaginosis, yeasts and trichomoniasis in Argentine women.
Rev Argent Microbiol. 2026;58:206-217.
PubMed
Abstract available

TANTITAMIT T, Vasuratna A, Khemapech N, Havanond P, et al
Cost-effectiveness of HPV catch-up vaccination program in women aged 13-24 years in a middle income country.
J Gynecol Oncol. 2026;37:e27.
PubMed
Abstract available

LIN CC, Chuang CC, Wang CY, Cheng SH, et al
The Cancer Screening Disparity among Women With Schizophrenia by Co-occurring Chronic Physical Illness Status: A Nationwide Cohort Study in Taiwan.
Schizophr Bull. 2026;52:sbaf206.
PubMed
Abstract available

KANAO H, Tamate M, Matsuura M, Nagao S, et al
Relationship between the lateral dissection lines of various radical hysterectomies and anatomical structures in the female pelvis: an educational video from the Sapporo Cadaver Surgical Workshop.
J Gynecol Oncol. 2026;37:e21.
PubMed
Abstract available

CHAULEUR C, Bourrely T
Robotic Single Port Retroperitoneal Para-aortic Lymphadenectomy, Staging for Advanced Squamous Cell Carcinoma of the Cervix.
J Minim Invasive Gynecol. 2026;33:374.
PubMed
Abstract available

MAHDAVI SABET F, Forghani S, Shahsavand A, Kharaghani M, et al
Diagnostic and clinical utility of ultrasound elastography for uterine cervical neoplasms-a comprehensive systematic review and meta-analysis.
Abdom Radiol (NY). 2026;51:2030-2043.
PubMed
Abstract available

CAIA C, De Maria F, Sopracordevole F, Ciavattini A, et al
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.
Eur J Cancer Prev. 2026;35:243-249.
PubMed
Abstract available

SAMAILA A, Isah A, Biambo AA, Usman N, et al
Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire.
J Oncol Pharm Pract. 2026;32:238-243.
PubMed
Abstract available

MARTINS TR, Witkin SS, de Oliveira RL, Gadelha JGS, et al
EVALUATION AND RECOMMENDATIONS TO MODERNIZE CERVICAL CANCER DETECTION AND PREVENTION PROGRAMS IN BRAZIL: CHALLENGES AND OPPORTUNITIES - A NARRATIVE REVIEW.
Acta Cytol. 2026 Mar 9:1-20. doi: 10.1159/000550725.
PubMed
Abstract available

HAN K
Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
Cancer. 2026;132:e70352.
PubMed

SANDOVAL TA, Li Y, Muhammad N, Desai T, et al
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.
Cancer Res. 2026 Mar 20:OF1-OF18. doi: 10.1158/0008-5472.CAN-25-3776.
PubMed
Abstract available

BAUDIN L, Zanella L, Lebeau A, Pleyers C, et al
Non-metastatic para-aortic lymph node remodeling as a predictor of outcome in locally advanced cervical cancer.
Clin Cancer Res. 2026 Mar 4. doi: 10.1158/1078-0432.CCR-25-3894.
PubMed
Abstract available

SCHEVENHOVEN VJC, Jansen EEL, Siebers AG, de Kok IMCM, et al
Long-term cervical cancer risk following negative hrHPV-based versus negative cytology-based screening: A population-based study.
Eur J Cancer. 2026;237:116601.
PubMed
Abstract available

WU SG, Hong SS, Tang YL, Zhou J, et al
Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy.
Eur J Obstet Gynecol Reprod Biol. 2026;321:115045.
PubMed
Abstract available

NAUMANN RW
Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cancer Trials Group Cx.5/SHAPE tr
Gynecol Oncol. 2026;205:A1-A2.
PubMed

JAIN D, Wahidi M, Effendi J, Hoang L, et al
Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
Gynecol Oncol. 2026;205:89-98.
PubMed
Abstract available

CUTRI-FRENCH C, Saris DH, Solorzano SS, Wang X, et al
Disparities in access to gynecologic oncology visits among elderly patients with gynecologic malignancies.
Gynecol Oncol. 2026;205:63-69.
PubMed
Abstract available

MOREL D, Parvu V, Andrews J, Stephenson P, et al
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
Gynecol Oncol. 2026;207:40-47.
PubMed
Abstract available

SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
Gynecol Oncol. 2023;177:95-102.
PubMed
Abstract available

SAAB R, Brazan A, Chisholm GB, Gonzales NR, et al
Clear cell carcinoma of cervix and vagina: A review of 63 cases in the post-DES era.
Gynecol Oncol. 2026;206:39-44.
PubMed
Abstract available

ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
Hum Pathol. 2026;170:106052.
PubMed
Abstract available

NEWTON R, Tenet V, Mugisha J, Kimono B, et al
Human papillomavirus infection and vaccination among young females in rural Uganda.
Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
PubMed
Abstract available

KARRBERG C, Gray P, Elfgren K, Milerad H, et al
Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
PubMed
Abstract available

LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
Predicting optimal impact interventions in the post-HPV vaccination world.
Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
PubMed
Abstract available

TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
PubMed
Abstract available

LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
Int J Cancer. 2026;158:2339-2358.
PubMed
Abstract available

QUAN J, Chen Q, Lan L, Zhang B, et al
Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in China.
Int J Cancer. 2026;158:2736-2746.
PubMed
Abstract available

ELFSTROM KM, Hortlund M, Ohman D, Dillner J, et al
Cancer detection using human papillomavirus self-sampling targeting long-term non-attenders in an organized cervical screening program.
Int J Cancer. 2026;158:2729-2735.
PubMed
Abstract available

HU Y, Liu Y, Guo W, Hong Z, et al
Efficacy and safety of 5-aminolevulinic acid-based photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HPV infections.
Int J Cancer. 2025 Dec 8. doi: 10.1002/ijc.70273.
PubMed
Abstract available

ZULFIKAROGLU E
Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
PubMed
Abstract available

HO QN, Quang Le T, Pham AHT, Nguyen PN, et al
Efficacy of thermal ablation among women with cervical intraepithelial neoplasia grade 1 and high-risk human papillomavirus genotypes: The first prospective study in Vietnam.
Int J Gynaecol Obstet. 2026;173:411-421.
PubMed
Abstract available

LIU X, Lyu Q, Li X, He L, et al
Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross-sectional study.
Int J Gynaecol Obstet. 2026;173:187-195.
PubMed
Abstract available

GULHAN I, Orun H, Yanigli G, Cagiran RN, et al
Human papillomavirus positivity and cervical intraepithelial lesion in cervical biopsy and endocervical curettage in women younger than 30 years.
Int J Gynaecol Obstet. 2026;173:209-215.
PubMed
Abstract available

MOEIN S, Romo FAL, Fischel LB, Singh N, et al
Fluorescein colposcopy-A more specific diagnostic method for detection of high-grade cervical precancer lesions than acetic acid.
Int J Gynaecol Obstet. 2026;173:138-143.
PubMed
Abstract available

ZHOU J, Cai J, Li X, Liu C, et al
Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study".
Int J Gynecol Cancer. 2026 Feb 11:104551. doi: 10.1016/j.ijgc.2026.104551.
PubMed

SANTIA MC, Morante-Caicedo C, Pineros Castillo WA, Taylor A, et al
Surgical de-escalation of cervical cancer treatment in limited-resource settings.
Int J Gynecol Cancer. 2026 Mar 2:102862. doi: 10.1016/j.ijgc.2025.102862.
PubMed
Abstract available

VIVEROS-CARRENO D, Agusti N, Mora-Soto N, Wilke RN, et al
De-escalation in definitive surgical management for cervical cancer.
Int J Gynecol Cancer. 2025 Oct 9:102711. doi: 10.1016/j.ijgc.2025.102711.
PubMed
Abstract available

CAICEDO-MARTINEZ M, Arbelaez-Marino AF, Arbelaez L, Farach A, et al
Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.
Int J Gynecol Cancer. 2026 Mar 2:102878. doi: 10.1016/j.ijgc.2025.102878.
PubMed
Abstract available

MORA-SOTO N, Viveros-Carreno D, Morante-Caicedo C, Pineros W, et al
Neoadjuvant chemotherapy in cervical cancer: a narrative review.
Int J Gynecol Cancer. 2026 Mar 2:102827. doi: 10.1016/j.ijgc.2025.102827.
PubMed
Abstract available

BROWN MH, Pollock AE, Sun K, Marter K, et al
Comparing Acute Toxicity of Proton and Photon Radiotherapy in Newly Diagnosed Gynecologic Primaries.
Int J Radiat Oncol Biol Phys. 2025 Nov 2:S0360-3016(25)06421.
PubMed
Abstract available

GULSTENE S, Chuk E, Conway J, Hanuschak J, et al
Dosimetric predictors of sexual toxicity in cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy.
Int J Radiat Oncol Biol Phys. 2026 Mar 18:S0360-3016(26)00505.
PubMed
Abstract available

MAYBURY EK, Ahmad S, McKenzie ND
Worldwide Evaluation of Cervical Cancer Self-Sampling Devices.
Obstet Gynecol. 2026 Feb 26. doi: 10.1097/AOG.0000000000006179.
PubMed
Abstract available

MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Radiother Oncol. 2023;188:109862.
PubMed
Abstract available

BONNAH J, Awuah B, Williams MS
The role of healthcare providers in shared decision making for cervical cancer prevention in Ghana: A qualitative study.
BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15785.
PubMed

CUI YM, Shan YM, Xiao YY, Gao Y, et al
Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
PubMed

OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
PubMed

WU M, Jiang Z, Xian X, Lu M, et al
Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
PubMed

CHEN X, Li J, Sun Y, Ye Z, et al
LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
PubMed

ABERA GB, Alemayehu M, Sori DA, Ali R, et al
Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
PubMed
Abstract available

CHHOKAR A, Joshi U, Keshavam CC, Gupta B, et al
Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions.
BMC Cancer. 2026;26:343.
PubMed
Abstract available

Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
PLoS One. 2026;21:e0343674.
PubMed

ARMIJO N, Espinoza MA, Contreras-Montiel P, Vera M, et al
Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.
PLoS One. 2026;21:e0332010.
PubMed
Abstract available

CUPERTINO BERGOMI L, de Souza Carvalho G, Zanetti de Albuquerque L, Goncalves Kischinhevsky D, et al
Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.
PLoS One. 2026;21:e0343651.
PubMed
Abstract available

CHEN Y, Qiu W, Xiao G, Zhang R, et al
Analysis of the correlation between vaginal microbiota and high-risk human papillomavirus infection and cervical lesions.
PLoS One. 2026;21:e0343027.
PubMed
Abstract available

MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
PLoS One. 2026;21:e0326551.
PubMed
Abstract available

HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
PLoS One. 2026;21:e0343764.
PubMed
Abstract available

AYASS MA, Zaman N, Griko N, Pashkov V, et al
Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions.
PLoS One. 2026;21:e0339693.
PubMed
Abstract available

AFAYA A, Awunyo W, Udeoha MA, Kodjo MM, et al
The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study.
PLoS One. 2026;21:e0344086.
PubMed
Abstract available

WU Q, Bai S, Wang P, Han L, et al
Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein.
PLoS One. 2026;21:e0343495.
PubMed
Abstract available

DAY S, Harries J, Sawula B, Payne A, et al
Navigating cancer: Insights from patient journey mapping.
PLoS One. 2026;21:e0327113.
PubMed
Abstract available

YAN K, Yang G, Yan L, Wu L, et al
Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
PLoS One. 2026;21:e0345286.
PubMed
Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum

;